395 related articles for article (PubMed ID: 29780321)
21. Targeting the TLR4 signaling pathway by polyphenols: A novel therapeutic strategy for neuroinflammation.
Rahimifard M; Maqbool F; Moeini-Nodeh S; Niaz K; Abdollahi M; Braidy N; Nabavi SM; Nabavi SF
Ageing Res Rev; 2017 Jul; 36():11-19. PubMed ID: 28235660
[TBL] [Abstract][Full Text] [Related]
22. Microglia in Alzheimer's disease.
Sarlus H; Heneka MT
J Clin Invest; 2017 Sep; 127(9):3240-3249. PubMed ID: 28862638
[TBL] [Abstract][Full Text] [Related]
23. Microglial activation and its implications in the brain diseases.
Dheen ST; Kaur C; Ling EA
Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
[TBL] [Abstract][Full Text] [Related]
24. The role of Galectin-3 in α-synuclein-induced microglial activation.
Boza-Serrano A; Reyes JF; Rey NL; Leffler H; Bousset L; Nilsson U; Brundin P; Venero JL; Burguillos MA; Deierborg T
Acta Neuropathol Commun; 2014 Nov; 2():156. PubMed ID: 25387690
[TBL] [Abstract][Full Text] [Related]
25. Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.
Derkow K; Krüger C; Dembny P; Lehnardt S
PLoS One; 2015; 10(8):e0135898. PubMed ID: 26288016
[TBL] [Abstract][Full Text] [Related]
26. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.
Peralta Ramos JM; Iribarren P; Bousset L; Melki R; Baekelandt V; Van der Perren A
Front Immunol; 2019; 10():80. PubMed ID: 30761145
[TBL] [Abstract][Full Text] [Related]
27. Regulation of innate immune responses in the central nervous system.
Bajramovic JJ
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):4-24. PubMed ID: 21143142
[TBL] [Abstract][Full Text] [Related]
28. TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia.
Lee JW; Nam H; Kim LE; Jeon Y; Min H; Ha S; Lee Y; Kim SY; Lee SJ; Kim EK; Yu SW
Autophagy; 2019 May; 15(5):753-770. PubMed ID: 30523761
[TBL] [Abstract][Full Text] [Related]
29. Review on Cross Talk between Neurotransmitters and Neuroinflammation in Striatum and Cerebellum in the Mediation of Motor Behaviour.
Abg Abd Wahab DY; Gau CH; Zakaria R; Muthu Karuppan MK; A-Rahbi BS; Abdullah Z; Alrafiah A; Abdullah JM; Muthuraju S
Biomed Res Int; 2019; 2019():1767203. PubMed ID: 31815123
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Toll-Like Receptor (TLR) Signaling Pathway by Polyphenols in the Treatment of Age-Linked Neurodegenerative Diseases: Focus on TLR4 Signaling.
Azam S; Jakaria M; Kim IS; Kim J; Haque ME; Choi DK
Front Immunol; 2019; 10():1000. PubMed ID: 31134076
[TBL] [Abstract][Full Text] [Related]
31. Emerging roles of protein kinases in microglia-mediated neuroinflammation.
Lee SH; Suk K
Biochem Pharmacol; 2017 Dec; 146():1-9. PubMed ID: 28684305
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
33. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
34. Toll-like receptors and inflammation in the CNS.
Lee SJ; Lee S
Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):181-91. PubMed ID: 14561199
[TBL] [Abstract][Full Text] [Related]
35. Brain-Resident Microglia and Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation in Neurodegenerative Disorders and Brain Cancer.
Sevenich L
Front Immunol; 2018; 9():697. PubMed ID: 29681904
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
Carty M; Bowie AG
Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.
Cassano T; Calcagnini S; Pace L; De Marco F; Romano A; Gaetani S
Front Neurosci; 2017; 11():30. PubMed ID: 28210207
[TBL] [Abstract][Full Text] [Related]
38. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.
Venezia S; Refolo V; Polissidis A; Stefanis L; Wenning GK; Stefanova N
Mol Neurodegener; 2017 Jul; 12(1):52. PubMed ID: 28676095
[TBL] [Abstract][Full Text] [Related]
40. Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis.
Van Der Putten C; Kuipers HF; Zuiderwijk-Sick EA; Van Straalen L; Kondova I; Van Den Elsen PJ; Bajramovic JJ
Glia; 2012 Jan; 60(1):43-52. PubMed ID: 21964955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
